← Back to Companies

Scholar Rock

Clinical-stage biopharmaceutical company developing innovative medicines by modulating protein growth factors to treat serious diseases including spinal muscular atrophy and other rare diseases. Publicly traded on NASDAQ (SRRK).

Location
Cambridge, Massachusetts, USA
Founded
2012
Investors
1
Categories
biotech, therapeutics, protein-modulation, rare-disease, public-company

Investors

NameLocationTypeStagesPortfolio
Polaris PartnersUSbiotech-focused-33